Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Petros Pharmaceuticals, Inc. Common Stock (PTPI)

Pharmaceutical Preparations

https://www.petrospharma.com

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists primarily of operations related to Stendra, which is sold generally in the United States, and H100 for the treatment of Peyronie's disease.

1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/02/2020

Market Cap

2,422,769

Shares Outstanding

2,200,000

Weighted SO

2,201,069

Total Employees

N/A

Upcoming Earnings

N/A

Beta

2.3210

Last Div

0.0000

Range

0.301-3.25

Chg

0.0125

Avg Vol

430006

Mkt Cap

2422769

Exch

NASDAQ

Country

US

Phone

973-242-0005

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

0.5880

EV Multiple

-0.2372

P/FV

0.2784

Div Yield %

0.0000

P/E

-0.1979

PEG

-0.0028

Payout

-89.6148

Current Ratio

1.4012

Quick Ratio

1.2576

Cash Ratio

0.7478

DSO

157.3607

DIO

268.9030

Op Cycle

426.2637

DPO

148.4261

CCC

277.8377

Gross Margin

0.5279

Op Margin

-3.8961

Pretax Margin

-1.7123

Net Margin

-3.1355

Eff Tax Rate

-294.7471

ROA

-0.5133

ROE

-1.3464

ROCE

-1.0567

NI/EBT

1.8311

EBT/EBIT

0.4395

EBIT/Rev

-3.8961

Debt Ratio

0.3033

D/E

0.8311

LT Debt/Cap

0.3828

Total Debt/Cap

0.4539

Int Coverage

0.1400

CF/Debt

-1.1460

Equity Multi

2.7399

Rec Turnover

2.3195

Pay Turnover

2.4591

Inv Turnover

1.3574

FA Turnover

23.2037

Asset Turnover

0.1637

OCF/Share

-1.1842

FCF/Share

-1.1842

Cash/Share

1.0097

OCF/Sales

-2.1232

FCF/OCF

1.0000

CF Coverage

-1.1460

ST Coverage

-4.5168

CapEx Coverage

0.0000

Div&CapEx Cov

-0.0076

P/BV

0.2784

P/B

0.2784

P/S

0.5880

P/E

-0.1979

P/FCF

-0.2769

P/OCF

-0.2923

P/CF

-0.2923

PEG

-0.0028

P/S

0.5880

EV Multiple

-0.2372

P/FV

0.2784

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation